CPC Subgroup
C12Y 108/01 with NAD+ or NADP+ as acceptor (1.8.1)
Full Title
Oxidoreductases acting on sulfur groups as donors (1.8) > with NAD+ or NADP+ as acceptor (1.8.1)
16 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 108/01002 Sulfite reductase (NADPH) (1.8.1.2)
- C12Y 108/01003 Hypotaurine dehydrogenase (1.8.1.3)
- C12Y 108/01004 Dihydrolipoyl dehydrogenase (1.8.1.4), i.e. lipoamide-dehydrogenase
- C12Y 108/01005 2-Oxopropyl-CoM reductase (carboxylating) (1.8.1.5)
- C12Y 108/01006 Cystine reductase (1.8.1.6)
- C12Y 108/01007 Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
- C12Y 108/01008 Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin
- C12Y 108/01009 Thioredoxin-disulfide reductase (1.8.1.9), i.e. thioredoxin-reductase
- C12Y 108/0101 CoA-glutathione reductase (NADPH) (1.8.1.10)
- C12Y 108/01011 Asparagusate reductase (1.8.1.11)
- C12Y 108/01012 Trypanothione reductase (1.8.1.12)
- C12Y 108/01013 Bis-gamma-glutamylcystine reductase (1.8.1.13)
- C12Y 108/01014 CoA-disulfide reductase (1.8.1.14)
- C12Y 108/01015 Mycothione reductase (1.8.1.15)
- C12Y 108/01016 Glutathione amide reductase (1.8.1.16)
- C12Y 108/01017 Dimethylsulfone reductase (1.8.1.17)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692